Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China
Gespeichert in:
| Veröffentlicht in: | Blood 2022-11, Vol.140 (Supplement 1), p.1598-1600 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1600 |
|---|---|
| container_issue | Supplement 1 |
| container_start_page | 1598 |
| container_title | Blood |
| container_volume | 140 |
| creator | Wang, Ying Wei, Xudong Yan, Dongmei Zhang, Cheng Zhou, Hongsheng Tong, Chunrong Mei, Heng Jin, Jie Niu, Ting Liang, Aibin Ren, Jienan Deng, Yiping Jin, Wei Feng, Yi Shi, Lin Wang, Yongzeng Haudenschild, Changting Lv, Lulu Wang, Jianxiang |
| description | |
| doi_str_mv | 10.1182/blood-2022-165002 |
| format | Article |
| fullrecord | <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_165002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122022054</els_id><sourcerecordid>S0006497122022054</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1852-ab86f8fed5ca90e9b0671435abd986e8d2ad08d850aa048c50d0465c3340701a3</originalsourceid><addsrcrecordid>eNp9UUuP0zAQDggkysIP4Obj7iF0nCapA6duWB5SBKu0nKOJPaEGN65spyj_HrdFHDnZ8nwvz5ckbzi85Vxky95Yq9IMsizlZQGQPU0WvMhEGq_wLFkAQJnm1Zq_SF56_xOA56usWDxJtpMPqEdSrKWD9l7bkeGo2AeSjtDH9y2dyOkwMzuwetOyXVqTMRFuMMTxRsWxJ_ZwojH4d2zDHvXJBjRsGyY1R9zRunAhf613vGK3esSgJfYBf9BIDKdgDU2SzB3bRc9wiEJMj1F5MoE9RvBZmf3WYX9xPcZUy5YGhzJYN7P7a6CNnAKxZj4c97Y36KMHa2j6Fb-F7LZdtv-ATXN31q_3Mcmr5PmAxtPrv-dN8v3jw67-nDbfPn2pN00quSiyFHtRDmIgVUisgKoeynVcYYG9qkRJQmWoQChRACLkQhagIC8LuVrlsAaOq5uEX3Wls947Grqj0wd0c8ehO1fYXSrszhV21woj5_2VQzHYSZPrvIy7kKS0Ixk6ZfV_2H8A6FylWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Wang, Ying ; Wei, Xudong ; Yan, Dongmei ; Zhang, Cheng ; Zhou, Hongsheng ; Tong, Chunrong ; Mei, Heng ; Jin, Jie ; Niu, Ting ; Liang, Aibin ; Ren, Jienan ; Deng, Yiping ; Jin, Wei ; Feng, Yi ; Shi, Lin ; Wang, Yongzeng ; Haudenschild, Changting ; Lv, Lulu ; Wang, Jianxiang</creator><creatorcontrib>Wang, Ying ; Wei, Xudong ; Yan, Dongmei ; Zhang, Cheng ; Zhou, Hongsheng ; Tong, Chunrong ; Mei, Heng ; Jin, Jie ; Niu, Ting ; Liang, Aibin ; Ren, Jienan ; Deng, Yiping ; Jin, Wei ; Feng, Yi ; Shi, Lin ; Wang, Yongzeng ; Haudenschild, Changting ; Lv, Lulu ; Wang, Jianxiang</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-165002</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.1598-1600</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1852-ab86f8fed5ca90e9b0671435abd986e8d2ad08d850aa048c50d0465c3340701a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Wang, Ying</creatorcontrib><creatorcontrib>Wei, Xudong</creatorcontrib><creatorcontrib>Yan, Dongmei</creatorcontrib><creatorcontrib>Zhang, Cheng</creatorcontrib><creatorcontrib>Zhou, Hongsheng</creatorcontrib><creatorcontrib>Tong, Chunrong</creatorcontrib><creatorcontrib>Mei, Heng</creatorcontrib><creatorcontrib>Jin, Jie</creatorcontrib><creatorcontrib>Niu, Ting</creatorcontrib><creatorcontrib>Liang, Aibin</creatorcontrib><creatorcontrib>Ren, Jienan</creatorcontrib><creatorcontrib>Deng, Yiping</creatorcontrib><creatorcontrib>Jin, Wei</creatorcontrib><creatorcontrib>Feng, Yi</creatorcontrib><creatorcontrib>Shi, Lin</creatorcontrib><creatorcontrib>Wang, Yongzeng</creatorcontrib><creatorcontrib>Haudenschild, Changting</creatorcontrib><creatorcontrib>Lv, Lulu</creatorcontrib><creatorcontrib>Wang, Jianxiang</creatorcontrib><title>Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9UUuP0zAQDggkysIP4Obj7iF0nCapA6duWB5SBKu0nKOJPaEGN65spyj_HrdFHDnZ8nwvz5ckbzi85Vxky95Yq9IMsizlZQGQPU0WvMhEGq_wLFkAQJnm1Zq_SF56_xOA56usWDxJtpMPqEdSrKWD9l7bkeGo2AeSjtDH9y2dyOkwMzuwetOyXVqTMRFuMMTxRsWxJ_ZwojH4d2zDHvXJBjRsGyY1R9zRunAhf613vGK3esSgJfYBf9BIDKdgDU2SzB3bRc9wiEJMj1F5MoE9RvBZmf3WYX9xPcZUy5YGhzJYN7P7a6CNnAKxZj4c97Y36KMHa2j6Fb-F7LZdtv-ATXN31q_3Mcmr5PmAxtPrv-dN8v3jw67-nDbfPn2pN00quSiyFHtRDmIgVUisgKoeynVcYYG9qkRJQmWoQChRACLkQhagIC8LuVrlsAaOq5uEX3Wls947Grqj0wd0c8ehO1fYXSrszhV21woj5_2VQzHYSZPrvIy7kKS0Ixk6ZfV_2H8A6FylWQ</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Wang, Ying</creator><creator>Wei, Xudong</creator><creator>Yan, Dongmei</creator><creator>Zhang, Cheng</creator><creator>Zhou, Hongsheng</creator><creator>Tong, Chunrong</creator><creator>Mei, Heng</creator><creator>Jin, Jie</creator><creator>Niu, Ting</creator><creator>Liang, Aibin</creator><creator>Ren, Jienan</creator><creator>Deng, Yiping</creator><creator>Jin, Wei</creator><creator>Feng, Yi</creator><creator>Shi, Lin</creator><creator>Wang, Yongzeng</creator><creator>Haudenschild, Changting</creator><creator>Lv, Lulu</creator><creator>Wang, Jianxiang</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China</title><author>Wang, Ying ; Wei, Xudong ; Yan, Dongmei ; Zhang, Cheng ; Zhou, Hongsheng ; Tong, Chunrong ; Mei, Heng ; Jin, Jie ; Niu, Ting ; Liang, Aibin ; Ren, Jienan ; Deng, Yiping ; Jin, Wei ; Feng, Yi ; Shi, Lin ; Wang, Yongzeng ; Haudenschild, Changting ; Lv, Lulu ; Wang, Jianxiang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1852-ab86f8fed5ca90e9b0671435abd986e8d2ad08d850aa048c50d0465c3340701a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Ying</creatorcontrib><creatorcontrib>Wei, Xudong</creatorcontrib><creatorcontrib>Yan, Dongmei</creatorcontrib><creatorcontrib>Zhang, Cheng</creatorcontrib><creatorcontrib>Zhou, Hongsheng</creatorcontrib><creatorcontrib>Tong, Chunrong</creatorcontrib><creatorcontrib>Mei, Heng</creatorcontrib><creatorcontrib>Jin, Jie</creatorcontrib><creatorcontrib>Niu, Ting</creatorcontrib><creatorcontrib>Liang, Aibin</creatorcontrib><creatorcontrib>Ren, Jienan</creatorcontrib><creatorcontrib>Deng, Yiping</creatorcontrib><creatorcontrib>Jin, Wei</creatorcontrib><creatorcontrib>Feng, Yi</creatorcontrib><creatorcontrib>Shi, Lin</creatorcontrib><creatorcontrib>Wang, Yongzeng</creatorcontrib><creatorcontrib>Haudenschild, Changting</creatorcontrib><creatorcontrib>Lv, Lulu</creatorcontrib><creatorcontrib>Wang, Jianxiang</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Ying</au><au>Wei, Xudong</au><au>Yan, Dongmei</au><au>Zhang, Cheng</au><au>Zhou, Hongsheng</au><au>Tong, Chunrong</au><au>Mei, Heng</au><au>Jin, Jie</au><au>Niu, Ting</au><au>Liang, Aibin</au><au>Ren, Jienan</au><au>Deng, Yiping</au><au>Jin, Wei</au><au>Feng, Yi</au><au>Shi, Lin</au><au>Wang, Yongzeng</au><au>Haudenschild, Changting</au><au>Lv, Lulu</au><au>Wang, Jianxiang</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>1598</spage><epage>1600</epage><pages>1598-1600</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-165002</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0006-4971 |
| ispartof | Blood, 2022-11, Vol.140 (Supplement 1), p.1598-1600 |
| issn | 0006-4971 1528-0020 |
| language | eng |
| recordid | cdi_crossref_primary_10_1182_blood_2022_165002 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T16%3A03%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sustained%20Remission%20and%20Decreased%20Severity%20of%20CAR%20T-Cell%20Related%20Adverse%20Events:%20A%20Pivotal%20Study%20Report%20of%20CNCT19%20(inaticabtagene%20autoleucel)%20Treatment%20in%20Adult%20Patients%20with%20Relapsed/Refractory%20B-Cell%20Acute%20Lymphoblastic%20Leukemia%20(R/R%20B-Cell%20ALL)%20in%20China&rft.jtitle=Blood&rft.au=Wang,%20Ying&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=1598&rft.epage=1600&rft.pages=1598-1600&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-165002&rft_dat=%3Celsevier_cross%3ES0006497122022054%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122022054&rfr_iscdi=true |